Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis

Free AI-powered analysis and research for Alnylam Pharmaceuticals, Inc. stock

Sector: Healthcare

Analyze Alnylam Pharmaceuticals, Inc. (ALNY) Stock

Alnylam Pharmaceuticals, Inc. (ALNY) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ALNY stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Alnylam Pharmaceuticals, Inc. stock.

Analyze ALNY Now →

📰 Latest Update

GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region

Wed, June 10, 2026 at 11:47 AM UTC 4 min read

GENESIS Pharma has expanded its strategic commercial partnership with Alnylam Pharmaceuticals to include the Nordic region for RNAi therapeutics. This expansion is significant for investors as it enhances Alnylam's market reach and potential revenue streams in a growing market for innovative therapies. The partnership underscores Alnylam's commitment to advancing its product offerings and could lead to increased sales and market presence in Europe.

Read full article →